STOCK TITAN
  1. Home
  2. Sec-filings
  3. PBYI
  4. [144] PUMA BIOTECHNOLOGY INC SEC Filing

[144] PUMA BIOTECHNOLOGY INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock PBYI logo
Puma Biotechnology Inc

NASDAQ:PBYI

PBYI Rankings

#5857 Ranked by Market Cap
N/A Ranked by Dividends

PBYI Latest News

Jul 2, 2025
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Jun 4, 2025
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 8, 2025
Puma Biotechnology Reports First Quarter Financial Results
May 6, 2025
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Apr 28, 2025
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025

PBYI Latest SEC Filings

Jul 10, 2025
[Form 4] PUMA BIOTECHNOLOGY INC Insider Trading Activity
Jul 10, 2025
[Form 4] PUMA BIOTECHNOLOGY INC Insider Trading Activity
Jul 10, 2025
[Form 4] PUMA BIOTECHNOLOGY INC Insider Trading Activity
Jul 9, 2025
[144] PUMA BIOTECHNOLOGY INC SEC Filing
Jul 9, 2025
[144] PUMA BIOTECHNOLOGY INC SEC Filing

PBYI Stock Data

174.73M
41.92M
15.35%
59.27%
6.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ANGELES